EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Future Directions and Pipeline Therapies for Hidradenitis Suppurativa

Kim T Nguyen, Daniella Jaguan, Noah Goldfarb

Dermatologic Clinics · 2025

DOI: 10.1016/j.det.2024.12.016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatologic Clinics, 2025. Verfasst von Kim T Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Minnesota, Minneapolis, MN, USA; College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Dermatologic Agents. Die Arbeit nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is a painful, autoinflammatory condition with dramaticimpact on quality of life. As of January 1, 2024, there are 25 phase I-III clinical trials for topical and systematic medications in the management of HS. Only three medications, adalimumab, secukinumab and bemikizumab, are currently approved by the United States Food and Drug Administration for the treatment of moderate to severe HS. In addition, 15 nonmedication-based studies are ongoing, including those for various surgical techniques, botulinum toxin, laser and light-based therapies, differing wound care methods, and a variety of complementary and alternative medicine practices for HS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaDermatologic AgentsHumansAntibodies, Monoclonal, HumanizedAdalimumabLaser TherapyComplementary TherapiesQuality of Life

Stichwörter der Autor:innen

Clinical trialsHidradenitis suppurativaManagementPipeline

Substanzen

Antibodies, Monoclonal, HumanizedDermatologic AgentsAdalimumabsecukinumab

Autor:innen und Institutionen

  • Department of Dermatology, University of Minnesota, Minneapolis, MN, USA; College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Georgetown University School of Medicine, Washington, DC, USA.
  • Department of Dermatology, University of Minnesota, Minneapolis, MN, USA; Department of Medicine, University of Minnesota, Minneapolis, MN, USA; Departments of Medicine and Dermatology, Minneapolis Veteran Affairs Healt…

Zitieren

APA

Nguyen, K. T., Jaguan, D., & Goldfarb, N. (2025). Future Directions and Pipeline Therapies for Hidradenitis Suppurativa. Dermatologic Clinics. https://doi.org/10.1016/j.det.2024.12.016

Vancouver

Nguyen KT, Jaguan D, Goldfarb N. Future Directions and Pipeline Therapies for Hidradenitis Suppurativa. Dermatologic Clinics. 2025. doi:10.1016/j.det.2024.12.016

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Kim T and Jaguan, Daniella and Goldfarb, Noah},
  title = {Future Directions and Pipeline Therapies for Hidradenitis Suppurativa},
  journal = {Dermatologic Clinics},
  year = {2025},
  doi = {10.1016/j.det.2024.12.016}
}
Kostenlos starten →